Publication | Closed Access
Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial
232
Citations
17
References
2013
Year
Neurodegenerative DiseasesAmyotrophic Lateral SclerosisNeurological DisorderClinical TrialsDexpramipexole Versus PlaceboNeurologyNeuroscienceNeurorehabilitationMedicine
| Year | Citations | |
|---|---|---|
Page 1
Page 1